Sysorex Elects Nasdaq-Listed Company CEO William Stilley to Board of Directors

September 13, 2021

Biotechnology

Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate

September 29, 2026
Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies

September 22, 2026
Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus(TM)

September 15, 2026
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics

September 15, 2026